The European medical cannabis market is developing unevenly - some countries have established access systems, others are still building regulations.
Diversity of regulatory models
Each country chooses its own model, from full reimbursement to a private prescription-based model. This affects availability and pricing.
The role of pharmacies and producers
Pharmacies and producers play a key role in product availability - their number and assortment vary significantly between countries.